ImmunoVaccine Technologies Inc.: federal grants and contributions: 18 agreements; $13.3M value; 2 departments; 6 programs.
Assay record ASY-CA-1Q0JCQ3109 · Cite as: Assay Systems, “ImmunoVaccine Technologies Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/immunovaccine-technologies-inc/
Evaluate Novel Adjuvant Systems in VacciMax
Development of DepoVax-based cancer immunotherapies
In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted peptide epitope approach has the potential to optimize and exceed the safety and efficacy profile of more conventional vaccines. DPX-COVID-19 utilizes a multi-target approach, to optimize immune response against virus’ weaknesses, enhance efficacy at preventing infection and reduce potential for immune escape, even in case of a virus mutation. Fully synthetic, DPX-COVID-19 has the potential for fast and large-scale manufacturing to supply a signific
Support pre-clinical development activities for COVID-19 vaccine
The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
This project aims to establish the clinical safety and immunogenicity of a vaccine candidate based on the Company’s DPX delivery technology and incorporating peptides targeting novel epitopes from the coronavirus strain. IMV believes that this peptide-based approach, combined with the portability of the DPX platform, offers the potential for accelerated development and rapid, large-scale production of a vaccine.
Facilitate a GMP clinical vaccine manufacture
Undertake marketing activities
Commercialization and business development activities
Hire a senior research scientist
Hire a consultant
This project will provide cyber security assistance to a priority covid response firm.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.